Three Organizations Developing Ebola Vaccines Amid Outbreak in Democratic Republic of Congo

Three organizations are developing Ebola vaccine candidates amid an ongoing outbreak in the Democratic Republic of Congo.

IAVI, Moderna, and the University of Oxford are all working on new vaccines. The vaccine candidates target a rare strain of Ebola caused by the Bundibugyo species.

Scientists are developing the three vaccine candidates in response to the outbreak. The Bundibugyo species has been identified as the cause of the current outbreak in the Democratic Republic of Congo.

According to reports, the outbreak has claimed nearly 250 lives in the Democratic Republic of Congo. The outbreak continues in the affected region.

The three vaccine candidates remain in development as health authorities respond to the situation. IAVI, Moderna, and the University of Oxford continue their respective vaccine development efforts targeting the rare strain of the virus.